DataMotion appoints Kathleen Crampton to Board of Directors

– USA, NJ – DataMotion, a health information service provider (HISP) with more than 15 years of experience in secure data delivery services, today announced the appointment of Kathleen Ridder Crampton to its Board of Directors. The company selected Crampton – a well-known executive with more than 30 years of successful management experience in healthcare – to help facilitate its continued rapid growth in the industry.

“Less than two years ago, DataMotion applied its long history in secure data delivery and work in healthcare to expand operations by becoming a HISP, and the growth that has followed is exceeding our highest expectations,” said Bob Bales, CEO DataMotion. “Kathleen Ridder Crampton is known for her leadership in healthcare. With the industry focused on adoption of electronic health records (EHR) – with an emphasis on secure, ‘real world’ communications that will produce better patient outcomes – her expertise will enable us to keep pace with growth and further enhance our leadership position.”

Added Crampton: “In a very short time, DataMotion has emerged as one of the leading HISPs. Already, nearly half of all EHR systems achieving 2014 ONC-ACB certification have done so using DataMotion Direct secure messaging service, enabling their providers to attest for Meaningful Use Stage 2 (MU2) and qualify for financial incentives. What distinguishes the company is their legacy in secure data delivery with proven industry expertise and technology already in place. I’m looking forward to working with this talented organization as they continue to grow and lead the way.”

Crampton’s record of success covers health insurance, hospital management, healthcare consulting, and involvement in early stage venture-funded companies. From 2009 to April 2014, she was president and CEO of United Healthcare of Florida, Inc. Community Plan (Florida Plan). A wholly owned subsidiary of United HealthCare Group – a Fortune 20 company – the Florida Plan is one of the largest providers of managed care services to the Medicaid population in Florida. She has also held President and CEO positions with Centene Corporation: Managed Health Services of Wisconsin and Buckeye Community Health Plan of Ohio.

Earlier in her career, Crampton held executive posts with such leading names as PriceWaterhouse Coopers, HealthTech Services, Harvard Pilgrim Health Plan, Boston Children’s Hospital Medical Center and Brigham and Women’s Hospital. She has received numerous honors, most recently being chosen the Commonwealth Foundation 2014 Outstanding Woman Leader in Florida. Crampton graduated from Boston University with a BA in American History, received an MPH in Public Health from Harvard University, and earned a MBA in Finance from George Washington University.

About DataMotion

DataMotion enables organizations to dramatically reduce the cost and complexity of delivering electronic information to employees, customers and partners in a secure and compliant way. The company’s easy-to-use solutions for Direct Secure Messaging, secure email, file transfer, forms processing and customer contact leverage the DataMotion Platform for unified data delivery. In 2012, DataMotion expanded operations as a health information service provider (HISP) with its DataMotion Direct Secure Messaging service, allowing healthcare organizations to meet emerging Meaningful Use Stage 2 (MU2) requirements. Millions of users worldwide rely on DataMotion to transparently improve business processes and reduce costs, while mitigating security and compliance risk. DataMotion is privately held and based in Florham Park, N.J. For the latest news and updates on DataMotion, visit, like DataMotion on Facebook® or follow DataMotion on Twitter® @datamotion.



- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.